The effect of exercise on high-level mobility in individuals with neurodegenerative disease: a systematic literature review by Smith, Moira et al.
ResearchOnline@JCU  
This is the author-created version of the following work:
Smith, Moira, Barker, Ruth, Williams, Gavin, Carr, Jennifer, and Gunnarsson,
Ronny (2020) The effect of exercise on high-level mobility in individuals with
neurodegenerative disease: a systematic literature review. Physiotherapy, 106 pp.
174-193. 
 
Access to this file is available from:
https://researchonline.jcu.edu.au/61983/
© 2019 Chartered Society of Physiotherapy. Published by Elsevier Ltd. All rights
reserved. In accordance with the publisher's policies, the Accepted Manuscript of this
article will be available Open Access from ResearchOnline@JCU, under a Creative
Commons Attribution Non Commercial No Derivative Work license, from 3 May
2020.
Please refer to the original source for the final version of this work: 
https://doi.org/10.1016/j.physio.2019.04.003
ResearchOnline@JCU  
This is the author-created version of the following work:
Smith, Moira, Barker, Ruth, Williams, Gavin, Carr, Jennifer J, and Gunnarsson,
Ronny (2020) The effect of exercise on high-level mobility in individuals with
neurodegenerative disease: a systematic literature review. Physiotherapy, 106 pp.
174-193. 
 
Access to this file is available from:
https://researchonline.jcu.edu.au/61983/
© 2019 Chartered Society of Physiotherapy. Published by Elsevier Ltd. All rights
reserved. In accordance with the publisher's policies, the Accepted Manuscript of this
article will be available Open Access from ResearchOnline@JCU from 3 May 2020.
Please refer to the original source for the final version of this work: 
https://doi.org/10.1016/j.physio.2019.04.003
Accepted Manuscript
Title: The effect of exercise on high-level mobility in
individuals with neurodegenerative disease: a systematic
literature review





To appear in: Physiotherapy
Please cite this article as: Smith M, Barker R, Williams G, Carr J,
Gunnarsson R, The effect of exercise on high-level mobility in individuals with
neurodegenerative disease: a systematic literature review, Physiotherapy (2019),
https://doi.org/10.1016/j.physio.2019.04.003
This is a PDF file of an unedited manuscript that has been accepted for publication.
As a service to our customers we are providing this early version of the manuscript.
The manuscript will undergo copyediting, typesetting, and review of the resulting proof
before it is published in its final form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that
apply to the journal pertain.
1 
 
The effect of exercise on high-level mobility in individuals with 
neurodegenerative disease: a systematic literature review. 
 
Authors 
Moira Smith1, Ruth Barker2, Gavin Williams3, Jennifer Carr4, Ronny Gunnarsson5.  
 
1College of Healthcare Sciences, Building 043-114, James Cook University, Townsville, 
Queensland, 4811, Australia. moira.smith2@jcu.edu.au. Tel: +61 7 47816003 
2College of Healthcare Sciences, James Cook University, Cairns, Queensland, 4878, 
Australia. ruth.barker@jcu.edu.au  
3University of Melbourne, Melbourne, Australia. Gavin.williams@epworth.org.au  
4College of Healthcare Sciences, James Cook University, Cairns, Queensland, 4878, 
Australia.  jennifer.carr2@my.jcu.edu.au  
5Primary Health Care, University of Gothenburg, Sweden. ronny.gunnarsson@infovoice.se  
 
Corresponding Author: Moira Smith 
Abstract 
Objective 
To investigate the effect of exercise on high-level mobility (i.e. mobility more advanced than 
independent level walking) in individuals with neurodegenerative disease.  
Data Sources 















Randomised controlled trials of exercise interventions for individuals with neurodegenerative 
disease, with an outcome measure that contained high-level mobility items were included. 
High-level mobility items included running, jumping, bounding, stair climbing and backward 
walking. Outcome measures with high-level mobility items include the High Level Mobility 
Assessment Tool (HiMAT); Dynamic Gait Index; Rivermead Mobility Index (RMI) or 
modified RMI; Functional Gait Assessment and the Functional Ambulation Category. 
Study appraisal 
Quality was evaluated with the Cochrane Risk of Bias Tool.  
Results  
Twenty-four studies with predominantly moderate to low risk of bias met the review criteria. 
High-level mobility items were included within primary outcome measures for only two 
studies and secondary outcome measures for 22 studies. Eight types of exercise interventions 
were investigated within which high-level mobility tasks were not commonly included. In the 
absence of outcome measures or interventions focused on high-level mobility, findings 
suggest some benefit from treadmill training for individuals with multiple sclerosis or 
Parkinson’s disease. Progressive resistance training for individuals with multiple sclerosis 
may also be beneficial. With few studies on other neurodegenerative diseases, further 
inferences cannot be made.   
Conclusion  
Future studies need to specifically target high-level mobility in the early stages of 
neurodegenerative disease and determine the impact of high-level mobility interventions on 













Systematic review registration number 
PROSPERO register for systematic reviews (registration number: CRD42016050362).     
Contribution of paper 
 Studies of interventions for individuals with neurodegenerative disease have not focussed 
on high-level mobility. 
 Little is known about the effectiveness of interventions for high-level mobility in the 
early stages of neurodegenerative disease 









High-level mobility can be defined as mobility more advanced than independent level walking 
[1]. High-level mobility can be lost by individuals in the early stages of a neurodegenerative 
disease, such as multiple sclerosis (MS), Parkinson’s (PD) and Huntington’s disease (HD), as 
progressive dysfunction of the neurons in the central nervous system occurs [2]. Mobility 













mobility is more advanced and includes running, jumping, leaping, bounding, backward 
walking and stair climbing. Participation in active sports, employment of a physical nature and 
engagement with young family members typically require high-level mobility. Accordingly, 
older individuals approaching retirement regularly seek a lifestyle with active leisure pursuits 
that demand high-level mobility [3]. Hence, for individuals with neurodegenerative disease, 
maintaining high-level mobility for as long as possible is important for participation and quality 
of life [4-7].  
Deterioration in mobility due to neurodegenerative disease occurs as a result of different 
pathological processes across the spectrum of the diseases e.g. basal ganglia dysfunction in PD 
and HD; interruption of neural transmission in MS and cerebellar degeneration in cerebellar 
ataxias [8-10]. These pathological processes lead to primary and secondary impairments in 
motor control, balance, coordination and strength [11-13] leading to a decline in mobility. 
Although age of onset, physical impairments and disease progression vary across the 
neurodegenerative diseases, the commonality is that these individuals are typically active and 
mobile at diagnosis. The challenge therefore, is to maintain high-level mobility for as long as 
possible to maintain participation and to maintain an active lifestyle [14, 15] to avoid 
progressive reduction in physical activity and associated risk of chronic lifestyle diseases such 
as cardiovascular disease, diabetes and obesity [16, 17].  
To date, exercise interventions designed for individuals with neurodegenerative diseases have 
been shown to increase strength, aerobic capacity and balance [18, 19]. In addition, recent 
research findings suggest that exercise can prevent or reduce disease progression for 
individuals with some neurodegenerative diseases [11, 20].  However, the impact of exercise 
interventions on basic mobility such as walking speed and stride length is unclear due to 
conflicting research findings [18, 19, 21-23]. Interestingly, little consideration has been given 













Consequently, the purpose of this systematic review was to investigate the effect of exercise 
interventions on high-level mobility in individuals with neurodegenerative disease.  
Methodology 
Protocol and registration 
A systematic review was conducted in accordance with the PRISMA statement [24] and was 
registered on the PROSPERO register for systematic reviews (registration number: 
CRD42016050362).     
Eligibility criteria 
Randomised controlled trials (RCTs) exploring exercise interventions and their effect on high-
level mobility in adults (≥ 18 years of age) with a neurodegenerative disease were included in 
this review. Studies that utilised an objective measure of mobility that contained high-level 
mobility items (i.e. running, jumping, leaping, bounding, backwards walking or stair climbing) 
analysed either as a single item or as part of a composite outcome measure, were included. 
Composite outcome measures usually combine performance on a range of mobility tasks to 
provide an overall score. Composite outcome measures, such as the High Level Mobility 
Assessment Tool (HiMAT) [25]; Dynamic Gait Index (DGI) [26]; Rivermead Mobility Index 
(RMI) [27]; modified RMI (mRMI) [28]; Functional Gait Assessment (FGA) [29] or the 
Functional Ambulation Category (FAC) [30] were included if they contained any high-level 
mobility items.  
Studies were excluded if they were not written in English, involved participants with co-
existing neurological diseases such as stroke, or if they only included multi-dimensional 
composite outcome measures in which the primary focus was not mobility (e.g. Functional 














Medline, CINAHL, Scopus, SportDiscus and PEDro databases were searched from the 
commencement period of each database to April 2018. Search terms used, keywords, MeSH 
terms and truncation symbols were applied as appropriate for each database (online 
supplementary information). Boolean operators were specifically used to connect a range of 
degenerative disease types and outcome measures containing high-level mobility items.  
Study selection 
Database searches were conducted by one reviewer (MS). Two reviewers (MS and JC) 
independently screened titles and abstracts, reviewed full text articles and decided if a study 
was to be included. Disagreements were resolved by consensus with a third reviewer if required 
(RB). Reference lists were screened and a citation search conducted on eligible full-text 
articles. 
Data collection and assessment of risk of bias 
Data extracted included participant diagnosis; participant characteristics; intervention; 
outcome measures and results. Information regarding risk of bias was independently collected 
using the Cochrane risk of bias tool [31] with data extracted on six domains of bias: selection 
bias; performance bias; detection bias; attrition bias; reporting bias and other bias. The 
Cochrane risk of bias tool allowed identification of high, low or unclear bias in each of these 
domains [31]. Where risk of bias was high in three or more domains, the study was classified 
as high risk of bias. Conversely, low risk of bias was classified by low risk of bias in all 
domains. The remainder of studies falling between these classifications were of moderate risk 
of bias. Disagreements or discrepancies were discussed and resolved by consensus (MS and 
JC) with a third reviewer if required (RB). 













Studies included in the systematic review were divided into subsets according to disease type. 
Common themes with regards to intervention were identified across the different 
neurodegenerative diseases and explored. Use of outcome measures containing high-level 
mobility items as a primary or secondary measure within each study was identified. Statistical 




The search resulted in 2344 studies following removal of duplicates (figure 1). After abstract 
screening, 61 studies were deemed eligible for full text review, 37 of which were excluded with 
a total of 24 studies included in this review (table 1). A meta-analysis of the data was deemed 
unsuitable due to the heterogeneity between studies in terms of disease severity, intervention 
and outcome measures utilised. Where similar outcome measures were used, the interventions 
varied [32-35] conversely, where interventions were similar the outcome measures varied [36-
38]. 
[Insert figure 1 here] 
Study population 
A total of 909 participants were included in the review with sample sizes for individual studies 
ranging from 10-110 participants with an age range of 23-89 years. Fifty-nine percent of 
participants were female. Across the 24 studies, 13 studies reported exercise interventions for 
individuals with MS (mean age 46; range 23-69 years) [32-35, 39-47], nine for PD (mean age 
68; range 48-89 years)  [36-38, 48-53], one for HD (mean age 51; range 23-75 years)  [54] and 













Studies on MS included participants with different types of MS i.e. relapse-remitting MS 
(RRMS), secondary progressive MS (SPMS) or primary progressive MS (PPMS). Mean 
disease duration ranged from 4.5-18 years for participants with MS, 5.8-11 years for 
participants with PD, 1-30 years for the participants with DCD and ≤ 14 years for participants 
with HD. 
Disease severity varied across studies from minimal to severe however all studies included 
participants with moderate disease severity (table 1). Moderate disease severity can be defined 
as an Expanded Disability Status Scale (EDSS) ≥ 3 for MS; Hoehn and Yahr stage 2-3 for PD; 
Unified Huntington’s Disease Rating Scale (UHDRS) motor > 42; Scale for Assessment and 
Rating of Ataxia (SARA) ≤ 11.5 for DCD.  
[Insert table 1 here] 
Quality assessment 
Methodological quality of the included studies varied with three studies demonstrating a low 
risk of bias in all categories of the Cochrane risk of bias tool (figure 2) [44, 46, 55]. Most 
studies were classified as having a moderate risk of bias. High risk of bias was evident in one 
study [54].  The most common issue was attrition bias, which was evident in ten studies. Only 
ten of the 24 studies reported a power calculation to inform sample size [38-40, 45-48, 52, 53, 
55]. Two studies failed to use adequate randomization and 14 studies had either unclear 
allocation concealment or no concealment. One study evaluating dance in PD [49] was a subset 
of a larger trial [48]. Lowest risk of bias was evident in MS studies, which supported use of 
treadmill training and task specific training [44, 46]. The only study on individuals with DCD 
[55] also demonstrated low risk of bias. 













Outcome measures  
Outcome measures designed specifically to assess high-level mobility e.g. the High Level 
Mobility Assessment Tool (HiMAT) [25], were not used in any of the included studies. Only 
two studies used a primary outcome measure that contained items of high-level mobility, one 
of which used timed stair ascent as part of a battery of measures [46], and the other a composite 
measure of mobility that included a high-level mobility item (Rivermead Mobility Index 
(RMI)) [45]. In the remaining 22 studies, secondary outcome measures that included high-level 
mobility items were either single-item measures or composite measures with a ceiling effect 
for high-level mobility items [56, 57]. Single item measures included timed stair ascent/descent 
in five studies [37, 39, 40, 42, 47] and backward walking in five studies [48-51, 54]. Composite 
measures of mobility were used in 12 studies, six of which used the Dynamic Gait Index (DGI) 
[32-36, 52], three used the Rivermead Mobility Index (RMI) or modified RMI (mRMI) [41, 
43, 44], two used the Functional Gait Assessment (FGA) [38, 53] and one used the Functional 
Ambulation Category (FAC) [55]. Outcome measures were recorded at baseline and post 
intervention in all studies and at follow up assessments in seven studies [35, 38, 39, 44, 47, 52, 
55] with a follow up period ranging from 4-48 weeks. 
Fifteen studies compared an experimental group (EG) with a control group (CG) [34-37, 39, 
40, 42, 43, 46-50, 53, 55]. Six studies compared two experimental groups (EG1, EG2) with a 
control group [32, 33, 38, 45, 51, 52] and three studies compared two different experimental 
groups (table 1) [41, 44, 54]. 
Intervention types 
Eight different intervention types in total were identified: task specific training, progressive 
resistance training, treadmill training, dance, video exercise gaming, balance rehabilitation, tai 












level mobility tasks within their intervention and these tasks consisted of stair climbing [35, 
41, 45], plyometrics [32] or dance [48, 49, 51, 53, 54].  
Duration of intervention programs ranged from 3-104 weeks with a median duration of eight 
weeks. Intervention frequency ranged from twice per week to daily, with twice per week most 
commonly applied [32, 34, 36, 38, 39, 45, 48-51, 54]. Where individual intervention session 
time was reported, session time ranged from 10-60 minutes. Measures of exercise intensity 
were commonly not reported (table 2). There were no significant adverse effects of any 
intervention reported. 
[Insert table 2 here] 
Task specific training (functional mobility) 
Two studies compared task-specific training (gait and stair retraining) to a facilitation approach 
(trunk mobilisation, stretching, and facilitation techniques) in individuals with MS [41, 45] 
with one study also comparing to no intervention [45]. Both approaches were individualised to 
participants and demonstrated significantly greater improvements on timed stair ascent [45]  
and RMI [41, 45] than no intervention with neither approach demonstrating greater benefit 
over the other. Location of intervention varied with one study conducted in a hospital outpatient 
setting [41] and the other study in a hospital outpatient setting for the task-specific training and 
the home environment for the facilitation techniques [45]. No significant differences were 
identified based on location of the intervention. 
Task specific training plus balance training and strengthening 
Task specific training was combined with balance and strength training, compared to no 
intervention in one study for DCD [55] and three studies for MS [35, 43, 46]. Task specific 













significant between group differences in the FAC were found in the DCD study and these 
improvements were maintained at 12-week follow up [55]. The three MS studies had 
conflicting results as one study demonstrated a statistically significant improvement in timed 
stair ascent [46], while the other two studies displayed no difference on the RMI [35, 43] and 
DGI [35, 43].   
Progressive resistance training 
Four studies investigated progressive resistance training in individuals with MS compared with 
a standardised exercise program [40], no-intervention [39, 47], or both comparators [32]. Two 
studies used ergometric devices for the progressive resistance training – one utilised a cycle 
ergometer and plyometric exercise [32] and another [40] used an eccentric ergometer 
recumbent stepper. The remaining studies used weights for progressive resistance training [39, 
47] with one study using fast concentric and slow eccentric control [39]. Three studies found 
statistically significant differences in favour of progressive resistance training groups in DGI 
[32] and timed stair ascent [32, 39, 47] with gains in stair ascent maintained in two studies at 
12 and 48 week follow up respectively [39, 47]. Contrary to this, another MS study found that 
those who received the standardised exercise program improved significantly more for the 
timed stair ascent than those who received progressive resistance training [40].  
Treadmill training 
Treadmill training was investigated in two studies for PD [36, 37] and one for MS [44] with 
progression of the intervention via incremental increases in speed in all three studies and 
treadmill incline in two of the studies [37, 44]. All studies found statistically significant 
improvements in mRMI [44], DGI [36] and timed stair ascent and descent [37]. Treadmill 
training was compared to no intervention in one PD study using DGI scores [36] and compared 













study, downhill decline resulted in significantly greater improvement than uphill incline on 
mRMI with changes maintained at four-week follow up [44].  
Dance 
Dance was explored in three studies with individuals with PD with all three studies sharing one 
common author [48, 49, 51]. Two studies reviewed Argentine tango compared to no 
intervention however, one study was a subset of the larger trial [48, 49]. The remaining study 
compared the effects of Argentine tango and American ballroom [51]. There was no difference 
between groups for backward walking velocity [48, 49, 51] but one study did identify a 
significant increase in backward stride length for both types of dance (tango and ballroom), 
compared to no intervention [51]. 
Video exercise gaming 
The effect of video exercise gaming was assessed in four studies [34, 38, 53, 54]. Two utilized 
the Wii Fit for balance, strength and yoga with MS and PD participants [34, 38] and two used 
a video dance game with PD and HD participants [53, 54]. In MS, there was no difference in 
DGI score between video exercise gaming and no intervention [34]. In PD, there was a 
statistically significant difference in FGA with use of video exercise gaming compared to a 
falls education control group but no difference compared to conventional exercise (stretching, 
strengthening and balance exercise) [38]. Improvements made with video exercise gaming and 
conventional exercise were maintained at one month follow up. Video dance gaming for PD 
participants did not improve FGA compared to no intervention [53].  In HD, video dance 
gaming led to a significant reduction in double support percentage in backward walking 
compared to handheld sedentary games but no difference in the change in backward velocity 














Balance exercises such as shifting centre of mass, altering base of support and dynamic 
activities during gait were assessed in two studies for participants with MS and PD [33, 52]. In 
the MS study, a statistically significant difference in the DGI was found for the combined use 
of motor and sensory strategies compared with motor strategies alone or a conventional non-
balance therapy control group [33]. In the PD study, no statistically significant differences were 
found on any of the outcome measures between no intervention and three intervention groups: 
i) an internal attentional focus ii) an external attentional focus iii) no attentional focus. The trial 
was halted at mid-point following an interim futility analysis [52]. 
Discussion 
This systematic review is the first to investigate the effect of exercise interventions on high-
level mobility in individuals with neurodegenerative disease. Across the 24 RCTs included in 
this review, high-level mobility was not the focus for measurement, and exercise interventions 
that were employed did not commonly include high-level mobility tasks. Furthermore, 
interventions were trialed with individuals across the spectrum of disease severity (EDSS 0-
10), many of which would not have been capable of performing high-level mobility tasks. 
Hence, review findings highlight that to date, exercise interventions for individuals with 
neurodegenerative conditions have not targeted high-level mobility nor have they specifically 
focused on participants who were capable of participating in and benefiting from high-level 
mobility tasks.  
Outcome measures 
High-level mobility was not exclusively assessed as a primary outcome in any of the studies in 













of primary outcome measures, with one study including a single item measure and [46] the 
second study using a composite score of mobility [45]. As composite outcome measures (e.g. 
DGI, FAC, and RMI) include a range of low and high-level items, significant improvement on 
these measures could have been achieved in the absence of improvement on the high-level 
items. For example, improvement in level walking and independence will increase the DGI 
score without a change in high-level mobility. The low representation of high-level mobility 
items within most composite measures renders them susceptible to a ceiling effect, therefore, 
an outcome measure that exclusively targets high-level mobility is recommended [56-58]. The 
only outcome measure that appears to be currently available that focuses on high-level mobility 
for populations with neuromusculoskeletal conditions, is the HiMAT [25]. Originally designed 
for use in traumatic brain injury, the psychometric properties of the HiMAT are yet to be 
investigated for individuals with neurodegenerative diseases. Recognising that the purpose of 
a high-level exercise intervention would be to increase or maintain community participation 
and an active lifestyle, inclusion of corresponding measures of community participation and 
physical activity levels would be indicated [59].  
Interventions 
Exercise interventions designed for individuals with neurodegenerative diseases appear to 
overlook the requirements for high-level mobility. Improving strength, control and skill 
acquisition in high-level mobility and sport is typically achieved via part-practice and task-
specific practice [60]. In order to achieve transference to specific high-level mobility activities, 
interventions need to address relevant components of the high-level mobility activity such as 
running, jumping and stair climbing. Running was not an intervention in any studies; stair 
climbing was used in only three studies [35, 41, 45] and jumping (plyometrics) in one study 













measurement was limited to backwards walking, which is unlikely to have fully represented 
changes in high-level mobility. 
Unpacking exercise interventions that have shown benefit for people with neurodegenerative 
diseases for even single items of high-level mobility (e.g. timed stair ascent/descent) may 
provide some insight into potentially effective interventions. Treadmill training, progressive 
resistance training and task-specific training are such examples for individuals with MS or PD 
[37, 39, 46, 47]. Treadmill training and progressive resistance training incorporated eccentric 
muscular strengthening (downhill walking, plyometric training and weighted resistance) 
indicating potential strength gain transference to high-level mobility [32, 37, 39, 44, 47]. Task-
specific training customised to the individual had a positive effect for participants with MS [41, 
45]. Due to the clinical heterogeneity of individuals with MS, this approach may have been 
effective because the participant was challenged at an appropriate level and on tasks relevant 
to their lifestyle. This customisation is important especially when considering the different 
classifications of MS and hence different functional capability of participants. 
Intervention intensity across included studies was commonly not reported (table 2) making it 
difficult to identify whether participants were working at an appropriate intensity in order to 
facilitate maximum change in high-level mobility. In addition, it is not possible to determine 
whether participants engaged in sufficient physical activity to meet the recommendations for 
prevention of chronic disease [17].  Challenging individuals at sufficient intensity with an 
appropriate exercise intervention requires assessment of risk. In the included studies there were 
no significant adverse effects reported which would indicate interventions were safe and 
feasible to provide. In the future, if interventions are modified to specifically target high-level 
mobility at the optimum intensity, then an assessment of feasibility and safety with this 














Inclusion of individuals at different stages of a disease, reflecting different functional levels 
will have reduced the probability of demonstrating a significant group difference in high-level 
mobility. For example, some MS studies included individuals with a range of classifications 
including RRMS, SPMS and PPMS or with different disease severity (EDSS). Similarly, PD 
participants varied in disease severity between stages I-IV Hoehn and Yahr scores. Participants 
with a lower functional level would not have been able to perform tasks that could be expected 
to improve high-level mobility. Additionally, to demonstrate efficacy, wide variability in a 
sample requires a much larger sample size than when variability is low [61]. An outcome 
measure is also required that has sufficient range to exclude the possibility of a ceiling or floor 
effect yet has the sensitivity to reveal significant change in any one individual in the study. 
Thus to demonstrate the impact of exercise interventions on high-level mobility, individuals 
targeted for inclusion in a trial need to have the capacity to benefit from high-level mobility 
interventions and outcome measures used need the necessary sensitivity to detect change in 
high-level mobility. 
Strengths and limitations 
This comprehensive review has provided a broad view of what is known about the impact of 
exercise interventions on high-level mobility within the population of people with 
neurodegenerative diseases. Included studies showed a large heterogeneity in disease severity 
(e.g. EDSS 0-10), interventions and outcome measures. Where similar outcome measures were 
used, the interventions varied [32-35] conversely, where interventions were similar the 
outcome measures varied [36-38]. Hence, a meta-analysis was deemed unsuitable due to the 













Studies were limited for neurodegenerative diseases of lower prevalence (e.g. DCD and HD) 
with several neurodegenerative diseases not featured at all (e.g. Friedreich’s ataxia, spinal 
muscular atrophy).  
Overall, studies included were of moderate to low risk of bias, with risk of bias largely limited 
by attrition. The probability of demonstrating benefits for high-level mobility was low as many 
included studies would not have been sufficiently powered due to smaller sample sizes (range 
n=10-110), and because power calculations would have been based on basic mobility (primary 
outcome measure) rather than high-level mobility. Power would also have been limited by high 
variability in disease severity, and therefore performance, coupled with use of measures that 
lacked the sensitivity to detect changes in high-level mobility [61]. While RCTs were selected 
in order to utilise level 2 evidence [62] inclusion of lower levels of evidence may have 
identified potential beneficial interventions or more challenging assessment of high-level 
mobility. In addition, non-English papers were excluded which creates the potential for 
selection bias.  
Future directions 
High-level mobility is important for community participation, subsequent quality of life and 
prevention of sedentary behaviours associated with chronic diseases [16, 17, 63]. Hence for 
individuals with neurodegenerative disease, there are three key considerations for future 
research. Primarily, exercise interventions need to be designed specifically to target high-level 
mobility, ideally in the early stage of the disease where participants have minimal impairment 
and are still able to actively participate in high-level tasks. Secondly, outcome measures are 
required that can detect changes in high-level mobility, community participation and physical 
activity levels as well as slowing of disease progression. Finally, further exploration of 














To date, exercise interventions for individuals with neurodegenerative disease have rarely 
included high-level mobility tasks, nor measured the impact of interventions on high-level 
mobility particularly in the early stage of disease when high-level mobility interventions would 
be most feasible.  Accordingly, future high quality studies need to specifically target high-level 
mobility in the early stages of neurodegenerative disease and determine the impact on high-
level mobility, community participation and levels of physical activity.  
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Figure 1. PRISMA flow diagram [24] 
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Table 1: Summary of included randomised controlled trials  




Follow up High-level mobility 
outcome measure 
Between group comparison  Outcome 
Parkinson’s Disease 
 
Cakit et al, 2007 
[36] 
54 Hoehn & Yahr 2-
3.  
Mean duration 
years (SD) 5.6 
(2.9) 
EG: treadmill  n=27            
CG: no intervention n=27 
8 weeks No follow up DGI  
(score) 
Mann-Whitney U-test Significant between group 





62 Hoehn & Yahr 
(SD)  
EG= 2.6 (0.1)  
CG= 2.5 (0.1) 
Mean duration 
years (SE)               
EG= 5.8 (1.1)                   
CG= 7.0 (1.0) 
EG: Argentine tango 
n=32     
CG: no intervention n=30 
12 months No follow up GAITRite.  
backward walking 
velocity (m/s) 
Repeated measures ANOVA with 
group and time. 
Tukey-Kramer between groups at 
given time 





10 Hoehn & Yahr 2-
3. Mean duration 
years (SE)                         
EG= 6.6 (7.5)       
CG= 11 (3.9) 
EG: Argentine tango n=5         
CG: no intervention  n=5 
24 months No follow up GAITRite.  
backward walking 
velocity (m/s) 
Repeated measures ANOVA with 
group and time 
Tukey-Kramer between groups at 
given time 
No significant main effects or 









EG= 8.7 (4.7)    
CG= 5.5 (3.3) 
EG: Tai Chi n=17     
CG: no intervention n=16 
13 weeks No follow up GAITRite.   
backward walking 
velocity (m/s)  
backward stride 
length (m) 
Independent t-tests  
Mann-Whitney Rank sum 
Backward velocity  
Non-significant between group 
difference in p=0.06  
Backward stride length 
Non-significant between group 




58 Hoehn & Yahr 1-
3. Mean duration 
years (SD) 
EG1= 9.2 (1.5) 
EG2= 6.9 (1.3) 
CG= 5.9 (1.0) 
EG1: waltz/foxtrot n=19  
EG2: tango n=19         
CG: no intervention n=20 
13 weeks No follow up GAITRite.   
backward walking 
velocity (m/s)  
backward stride 
length (m) 
Repeated measures ANOVA with 
group and time. 
Holm-Sidak post-hoc tests 
Backward velocity  
No significant between group 
difference p>0.05 
Backward stride length 
Significant between group difference 
p=0.05: EG1 & EG2 increased 
backward stride length, CG reduced 
backward stride length. 
Time p=0.008 
Kurtais et al, 
2008 [37] 
27 Hoehn & Yahr 
(SD)       
EG= 2.5 (0.7) 
CG= 2.2 (0.8)               
Mean duration 
years (SD)    
EG= 5.3 (0.8)   
EG: treadmill/flexibility 
n=13       
CG: flexibility exercises 
n=14  
6 weeks No follow up Ascending/ 
descending stairs, 
(seconds) 
Mann-Whitney U test Significant between group 















CG= 5.4 (1.2) 
Landers et al, 
2016 [52] 
49 Hoehn & Yahr 
scale range 1.5-4 
EG1: balance external 
focus n=12  
EG2: balance internal 
focus n=13  
EG3: balance no 
attentional focus n=12   
CG: no intervention n=12 





Repeated measures ANOVA with 
group and time. 
 
Secondary analysis of combined 
EG (EG1, EG2, EG3) compared to 
CG 
 
No statistically significant between 
group differences p=0.40 
  
No statistically significant between 
group difference of combined EG 
(EG1, EG2, EG3) and control p=0.6 
Liao et al, 2015 
[38] 
36 Hoehn & Yahr 
(SD) 
EG1= 2.0 (0.7) 
EG2= 2.0 (0.8) 
CG= 1.9 (0.8)    
Mean duration 
years (SD)    
EG1= 7.9 (2.7) 
EG2= 6.9 (2.8) 
CG= 6.4 (3.0) 
EG1: Wii Fit & treadmill 
n= 12 
EG2: exercise & 
treadmill n=12            
CG: falls prevention 
education n=12 





Tukey post hoc test 
Statistically significant between 
improvement for EG1 & EG2 vs CG 
p<0.05 
No statistically significant difference 
between EG1 & EG2 p>0.05  
Song et al, 2018 
[53] 
60 Hoen & Yahr NR 
Mean duration 
years (SD)    
EG= 7 (4) 
CG= 9 (6) 
EG: video dance game 
n=31 
CG: no intervention n=29 
12 weeks No follow-up FGA 
(score) 
repeated measures ANOVA No statistically significant between 




Cakit et al, 2010 
[32] 




EDSS ≤ 6 
EG1: cycling PRT & 
exercise n=15 
EG2: exercise  n=15 
CG: no intervention n=15 
8 weeks No follow up DGI 
(score) 
One-way ANOVA 
Tukey post hoc test 
Significant between group difference 
in favour of EG1:  
EG1-EG2 p<0.001 
EG2-CG NS 
EG1-CG p<0.01).   
Cattaneo et al, 
2007 [33] 
50 RRMS; SPMS 
OR PPMS. Mean 
duration years 
(SD) 
13.8 (8.1)  
EDSS NR 
EG 1: balance rehab 
motor/sensory n=23;  
EG 2: balance rehab 
motor n=12 
CG: conventional non-
balance n=15.   
3 weeks No follow up DGI 
(score) 
One-way ANOVA 
Newman-Keuls post hoc test 
Statistically significant between 
group differences in favour of EG1 
p=0.04 compared to CG.  
No significant between group 
difference for EG1 vs EG2 p=0.08 
Dalgas et al, 
2009 [39] 
38 RRMS.        Mean 
duration years:  
EG= 6.6           
CG= 8.1   
EDSS range 3.0-
5.5 
EG: PRT lower limb 
n=19 
CG: no intervention n=19 






Follow-up: paired t-test 
Significant between group difference 















Hayes et al, 
2011 [40] 
22 MS.  Mean 
duration years 
(SD)   
2.2 (8.1) 
EDSS mean (SD) 
5.24 (0.96) 
EG1: eccentric resistance 
training plus standard 
exercise n= 11 
CG: standard exercise 
n=11 




Repeated measures ANOVA with 
group and time. 
 
Significant between group 
difference, CG improved, EG did not 
p=0.02 
Kjolhede et al, 
2015  [47] 
35 RRMS. Median 
duration years 
(range): 5 (0.5-28) 
EDSS range 2-4 
EG: PRT upper and lower 
limbs 
CG: no intervention 
24 weeks 48 weeks Ascending stair 
climbing test 
(seconds) 
Two way repeated measures 
ANOVA 
Significant between group difference 
in favour of EG p<0.01, maintained 
at follow-up 
Lord et al, 1998 
[41] 
23 Progressive or 
RRMS. Mean 
duration years 
(SD)         
EG1=  14 (8.1) 
EG2= 18.3 (7.0)               
EDSS NR 
EG1: task oriented n=11 
EG2: facilitation n=12 
 




Mann-Whitney U test 
Student’s unrelated t-test 
Significant improvement in EG1 & 
EG2 p<0.05.  No significant 
difference between groups p>0.05 
Nilsagard et al, 
2013 [34] 
84 RRMS  , SPMS; 
PPMS          Mean 
duration years 
(SD) 
EG = 12.5 (8.0) 
CG 12.2 (9.2) 
EDSS NR 
EG: Wii Fit balance n=42 
CG: no intervention n=42 
6-7 weeks No follow up DGI 
(score) 
Mann-Whitney U test 
 
No statistically significant between 
group difference p=0.21 ES=0.34 
Pfalzer & Fry, 
2011 [42] 
46 RRMS, SPMS, 
PPMS 
EDSS range 2-6.5 
EG: inspiratory muscle 
training n=23 
CG: no intervention n=23 
10 weeks No follow up Functional stair 
test 
(seconds) 
Repeated measures ANOVA No statistically significant between 





21 RRMS  , SPMS; 
PPMS          Mean 
duration years   
(SD)     
EG= 17.6 (10.0)                
CG= 15.9 (11.9) 
EDSS range 4-6.5 
EG: task specific 
training, balance & 
strength n=10  
CG: no intervention n=9        
2 exclusions: group 
allocation not provided 
3 weeks No follow up Rivermead 
mobility index 
(score) 
Mann-Whitney U test 
 
No statistically significant between 
group differences p=0.35 
Samaei, 2016 
[44] 
34 RRMS Mean 
duration years 
(SD)             EG1= 
4.8 (3.3) 
EG2= 4.5 (2.8) 
EDSS NR 
EG1: downhill treadmill 
n=17  
EG2: uphill treadmill 
n=17  




Repeated measures ANOVA 
Tukey post hoc test 
Significant improvement in EG1 
p=0.009 & EG2 p=0.038.  
Between groups EG1 improved more 
than EG2 at post intervention 
p=0.005 and at follow-up p=0.009  
Straudi, 2014 
[35] 
24 RRMS  , SPMS; 
PPMS          Mean 
duration years 
(SD)    
EG= 12.2 (6.9)   
CG 18.25 (9.46) 
EG: task specific training 
& home exercise n=12 
CG: no intervention n=12 
Intervention  
i) 3 weeks.  
Intervention 







Post hoc analysis only performed 
if significant within group 
differences 
No significant change over time 













EDSS Mean (SD) 
4.9 (0.5) 
Tarakci et al, 
2013 [46] 
110 RRMS  , SPMS; 
PPMS             Mean 
duration years 
(SD) 
EG=9 (4.7)               
CG=8.4 (5.4) 
EDSS range 2-6.5 
EG: group task specific 
training, balance and 
strength 
CG: no intervention 
12 weeks no follow up Ascending stair 
climbing test * 
(seconds) 
Student’s t test statistically significant between 








EDSS range 0-10 
42 patients per group 
(crossover trial) 
EG1: home based task-
oriented approach 
EG2: hospital outpatient - 
facilitation techniques 
CG: no intervention 
8 weeks No follow up Rivermead 




90% power for 1 unit difference at 
α=0.05 
Statistically significant between 
group difference: EG1 & EG2 
improved compared to CG p<0.001.  
No statistically significant between 
group difference for E1 & E2 p=0.77 
Huntington's Disease 
  
Kloos et al, 
2013 [54] 
24 UHDRS motor 
score: 
≤ 42 n=10 
UHDRS motor 
score >42 n=8 
Mean duration 
years (SD)  
5 (4) 
EG: video dance game 
n=13      
CG: sedentary handheld 
game n=11 








linear regressions model Statistically significant between 
group change in backward double 
support percentage, EG improved 
compared to CG p=0.01.  No 
statistically significant between 
group difference for backward stride 
length p=0.4 or velocity p=0.8 
Degenerative cerebellar ataxia 
   
Miyai et al, 
2012 [55] 
42 spinocerebellar 
ataxia:   
SCA type 6 n=20 







SARA mean (SE) 
EG:12.2 (0.7) 
CG: 11.0 (0.8) 
EG: task specific 
training, balance and 
strength n=21    
CG: delayed entry n=21 
 





Wilcoxon rank-sum test Statistically significant between 
group difference in favour of EG 
after 4 weeks p<0.05, maintained at 
12 week follow-up p<0.01 
* Primary outcome measure  
KEY: ANOVA=analysis of variance; ANCOVA=analysis of covariance; CG=control group; DGI=dynamic gait index; EDSS=Expanded Disability Status Scale; EG=exercise group; FAC=functional ambulation category; 
FGA=functional gait assessment; m=metres; mRMI=modified Rivermead mobility index; m/s=metres per second; n=number of participants; NR=not reported; NS=non-significant; PPMS=primary progressive multiple 
sclerosis; PRT=progressive resistance training; RRMS=relapse remitting multiple sclerosis; SARA= Scale for Rating and Assessment of Ataxia; SCA=spinocerebellar ataxia; SD=standard deviation; SE=standard error; 













Table 2: Summary of interventions used in included trials 
Author/ 
Year  










Duration  Intensity  Inline/ 
decline 
Sets Repetitions Progression 
Parkinson's disease 
Cakit et al, 
2007 [36] 
EG: treadmill 
training   
  CG: no 
intervention 
8 weeks 2 x week / 
16 sessions 
30 ± 5 
minutes 
5 minute 



























tango classes  
Leading and following roles. 
Frequent partner change. 
CG: no 
intervention 
12 months 2 x week / 
104 
sessions 
60 minutes NR  NA  NA  NA Learning 
new steps, 
integration 





tango classes  
  CG: no 
intervention 
24 months 2 x week / 
208 
sessions 




EG: Tai Chi.  First and second circles of 






2x week / 
20 sessions 






EG2: Dance tango   
Leading and following roles. 





2 x week / 
20 sessions 
60 minutes NR  NA NA  NA  NR 
Kurtais et al, 
2008 [37] 
EG: treadmill 
training & home 
flexibility 
exercises 
Home flexibility exercise NR CG: home 
flexibility 
exercises 
6 weeks 3 x week / 
18 sessions 
























al, 2016 [52] 
EG1: balance 










Balance training: 10 minutes 
treadmill; 10 minutes 
obstacle negotiation; 10 
minutes balance training 
tasks in harness. 
CG: no 
intervention 
4 weeks 3 x week / 
12 sessions 















treadmill training                                
EG2: exercise & 
treadmill training 
EG1: 10 minutes yoga; 15 
minutes strengthening; 20 
minutes balance game; 15 
minutes treadmill training.  
EG2: 10 minutes stretching; 
15 minutes strengthening - 
gross lower limb movements; 
20 minutes dynamic balance 






6 weeks 2 x week / 
12 sessions 









 NR EG1; NR        
EG2:strengtheni
ng 3 sets 
EG1: NR    
EG2: 
strengthenin
g 10 reps 
EG 1 & 2 
strengthenin




Song et al, 
2018 [53] 
EG: video dance 
game 
 
EG: step activated dance pad 
following 6 multi-directional 
arrows.          
CG: no 
intervention 
12 weeks 3 x week/ 
36 sessions 













program.                
EG 2: exercise 
program 
EG1: progressive resistance 
training on cycle ergometer.  
EG1 & 2: exercise 
programme: 5 minutes warm 
up; 20-25 minutes dynamic 
balance exercise - balance 
board, plyometrics; 5 minutes 
whole body stretching  
CG: no 
intervention 

















 NA EG1: 15 sets of 
cycle program 
 




 NA EG1: 12 
successful 
sets at cycle 
workload 















al, 2007 [33] 
EG 1: balance 
rehabilitation 
using motor and 
sensory strategies.   





Motor strategies: dynamic 
standing tasks, limits of 
stability and biofeedback.                  
Sensory strategies: dynamic 





nal therapy" not 
aimed at 
balance 
3 weeks 3-4 x week 
/ 10-12 
sessions 






exercises in a 
variable 
environment 




limb training  
5 minutes stationary cycle 
warm up. Fast concentric and 
slow eccentric exercises: leg 
press, knee extension; hip 




12 weeks 2 x week / 
24 sessions 
NR  NR  NA Weeks 1-4: 3 
sets; weeks 5-
10: 4 sets; weeks 
11-12: 3 sets. 
Weeks 1-2: 
10 reps of 
15RM; 
weeks 3-6: 
12 reps at 
12RM; 
weeks 7-8: 
10 reps at 
10RM; 
weeks 9-12 8 
reps at 8RM. 
Weeks 1-2: 
10 reps of 
15RM; 
weeks 3-6: 
12 reps at 
12RM; 
weeks 7-8: 
10 reps at 
10RM; 
weeks 9-12 8 
reps at 8RM. 
Hayes et al, 
2011 [40] 




resistance training  
plus standard 
exercise training  
EG: eccentric recumbent 
stepper 
plus: standard exercise 
training: 15 minutes 
recumbent stepper; lower 
limb stretching; upper limb 




training as per 
EG 








 NA Standard exercis

















al, 2015 [47] 
EG: PRT upper 
and lower limbs 
Lower limb exercises: leg 
press, hip flexion, leg 
extension, prone hamstring 
curl. 
Upper limbs: cable pull 




24 weeks 3 x week / 
72 sessions 
NR NR NA Weeks 1-6: 3 
sets; weeks 7-
12: 4 reps; 
weeks 13-14: 3 
reps; weeks 15-
22: 4 reps; 
weeks 23-24: 5 
reps. 
weeks 1-2: 
10 reps of 
15RM; 
weeks 3-4: 
12 reps of 
15RM; 
weeks 5-6: 
10 reps of 
12RM; 
weeks 7-8: 
10 reps of 10 
RM; weeks 
9-10: 8 reps 
of 8 RM; 
weeks 1-2: 
10 reps of 
15RM; 
weeks 3-4: 
12 reps of 
15RM; 
weeks 5-6: 
10 reps of 
12RM; 
weeks 7-8: 
10 reps of 10 
RM; weeks 
9-10: 8 reps 




















10 reps of 
10RM;  
weeks 19-20: 
8 reps pf 
8RM; weeks 
21-24 6 reps 
of 6RM. 
weeks 11-12: 






10 reps of 
10RM;  
weeks 19-20: 
8 reps pf 
8RM; weeks 
21-24 6 reps 
of 6RM. 





EG1: task specific training – 
gait, dynamic stepping, stairs  
EG2: facilitation; dynamic 
gait re-education; dynamic 





5-7 weeks 3 x week / 
15 sessions 










al, 2013 [34] 
EG:  Wii Fit 
balance exercises  
Video exercise game of 




6-7 weeks 2 x week / 
12 sessions 















10 weeks daily 10-15 
minutes 




EG: task specific 
training and 
exercise  
Session 1: individualised 
physiotherapy.  
Session 2: treadmill training. 
Session 3: functional gait & 
balance exercise.  
Session 4: strength-training 
ergometry.  




3 weeks 4-5 
sessions 5 









2 ½ hours 
NR  NR  Individualised  Individualis
ed 
Individualise










4 weeks 3 x week / 
12 sessions 






























home exercise  
Intervention i) circuit: step 
ups; slalom; tandem walking; 
step targets; obstacles; long 
steps; treadmill 30 minutes.  
ii) independent home 





n i) 3 
weeks.  
Interventio
n ii) 3 
months 
Interventio
n i) 5 x 
week / 10 
sessions.  
Interventio
n ii) 3 x 
week  
Interventio
n i) 120 
minutes.  
Interventio
















al, 2013 [46] 
EG: group task 
specific training 






12 weeks 3 x week / 
36 sessions 




NA NR NR NR 
Wiles, 2001 
[45] 
EG1: physio at 









solving approach.  
EG1: functional activities: 
stairs, mobility, community 




8 weeks 2 x week / 
16 sessions 




Kloos et al, 
2013 [54] 
EG: video game 
dance exercise 
EG: step activated dance pad 
following 4 multi-directional 
arrows in time to music.         
CG: bingo; blackjack or 
solitaire 




6 weeks 2 x week / 
12 sessions 






Degenerative cerebellar ataxia 
Miyai et al, 
2012 [55] 
EG: task specific 
active exercise for 
balance, gait and 
coordination 
activities.   
General conditioning; 
stretching; strengthening; 
balance exercise; spine 
mobilisation; ADL functions; 
coordination tasks. 
CG : no 
intervention 
4 weeks 11 sessions 
week / 44 
sessions 
60 minutes NR  NA  NR NR  NR 
Key: ADL=activities of daily living; MHR=maximum heart rate; NR=not reported; NA=not applicable; RM=repetitions maximum; RPE=rating of perceived exertion; TMW=tolerated maximum workload; W=watts 
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